• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AGN 1.71% 59.5¢

ARGENICA THERAPEUTICS LIMITED

Argenica Therapeutics Limited is an Australia-based clinical drug development company.... Argenica Therapeutics Limited is an Australia-based clinical drug development company. The Company is focused on developing therapeutics to reduce brain tissue death after stroke and other types of brain injury and neurodegenerative diseases to improve patient outcomes. The Company's lead candidate, ARG-007, is a cationic arginine-rich peptide that aims to protect brain cells and reduce cell death following a stroke, and other types of neural injury, in order to minimize the impact of these conditions and improve patient recovery. ARG-007 has been successfully demonstrated to improve outcomes in pre-clinical stroke models, traumatic brain injury (TBI) and hypoxic ischaemic encephalopathy (HIE). More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
AGN
AGN Media thread
2
05/05/24 77 22K
05/05/24 Last post  Investie Comments Created with Sketch.  77  Views Created with Sketch.  22K 
AGN 29/04/24 3 1.2K
29/04/24 Last post  TradingHault Comments Created with Sketch.  3  Views Created with Sketch.  1.2K 
AGN 24/04/24 1 506
24/04/24 Last post  TradingHault Comments Created with Sketch.  1  Views Created with Sketch.  506 
AGN 23/04/24 58 13K
23/04/24 Last post  chelseadude65 Comments Created with Sketch.  58  Views Created with Sketch.  13K 
AGN 22/04/24 6 1.1K
22/04/24 Last post  daveg Comments Created with Sketch.  6  Views Created with Sketch.  1.1K 
AGN 22/04/24 0 174
22/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  174 
AGN
News: AGN Argenica Therapeutics Successfully Completes A$12.0M Placement
12/04/24 0 202
12/04/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  202 
AGN 12/04/24 0 181
12/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  181 

See All Discussions arrow Created with Sketch.

Timeline

DSMB Confirms Safety of First Patients Dosed
29 Apr 09:02
 
Quarterly Activities/Appendix 4C Cash Flow Report
24 Apr 08:47
 
Cleansing Notice
22 Apr 09:18
 
Application for quotation of securities - AGN
22 Apr 09:16
 
Proposed issue of securities - AGN
12 Apr 09:14
 
Proposed issue of securities - AGN
12 Apr 09:14
 
View More arrow Created with Sketch.
(20min delay)
Last
59.5¢
Change
0.010(1.71%)
Mkt cap ! $73.07M
Open High Low Value Volume
60.0¢ 61.5¢ 59.0¢ $78.11K 130.6K

Buyers (Bids)

No. Vol. Price($)
1 4999 59.5¢
 

Sellers (Offers)

Price($) Vol. No.
60.0¢ 19915 1
View Market Depth
Last trade - 16.10pm 06/05/2024 (20 minute delay) ?
Last
60.5¢
  Change
0.010 ( 4.31 %)
Open High Low Volume
59.0¢ 61.0¢ 59.0¢ 61277
Last updated 15.23pm 06/05/2024 ?
AGN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.